The greatest life-science developments of 2004 ( rsities and top research institutions. ...)

The greatest life-science developments of 2004

rsities and top research institutions. By the way, the Shanghai Zhangjiang Hi-Tech Park includes both facilities for Roche and Eli Lilly.

Intellectual Property Protection:

This has been an area of major concern to American and European pharmaceutical companies. Before 1993, China didnt grant drug patents. China was granted entry into the World Trade Organization in 2001. Th......

Full article >>>

Source:wistechnology.com By Michael Rosen 12/21/04

Page: 1 2 3 4 5 6 7
Related biology technology :

1. Historic lists - The greatest rock bands, rock guitarists of all time
2. A Midwest life-science odyssey comes full circle
3. A Midwest small-cap, life-science surprise package
4. Madison life-science firms agree to co-develop kidney product
5. Does Milwaukee need a life-science spark?
6. The top 10 misconceptions of life-science patents
7. British, Wisconsin firms explore life-science opportunities together
8. Midwest large-cap life-science sector is solid in first quarter
9. Bio-Logic Systems, another Midwest life-science firm, flies under the radar
10. Midwest life-science company Perrigo globalizes under the radar
11. Recent developments in the protection of trademarks on the Internet

Post Your Comments:

(Date:11/24/2009)... , REYKJAVIK, Iceland, Novembe...c. (Nasdaq: DCGN ) today announced the approval of...ptcy Court for the District of Delaware,(the "Bank... petition for,relief under Chapter 11 of the Unite.... , The orders issued by the Bankruptcy C...

(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/...ood & Drug Administration (SFDA) has approved ... its oral insulin project,(Nodlin), an innovative ...proval allows Biolaxy to initiate its first phase ...r characteristic of high blood glucose and poor,me...

(Date:11/24/2009)... , , Primary efficacy endpoint has been met... endometrial cancer, , QUEBEC CITY, Nov. 24 /...DAQ: AEZS ; TSX: AEZ) (the "Company"), a global b...apy and oncology, today announced positive efficac...toxic peptide conjugate, AEZS-108 (formerly AN-152...

(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fir...RNA ) announced today that the company is schedu...alth Care Conference on December 1, 2009 at 11:30 ...New York Palace Hotel in New York City. Jack Lief,... scheduled to provide an overview of the company, ...

Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2 deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3 Biolaxy Secures IND Approval for Oral Insulin 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4 Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2 Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3

[0] deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court [0] Biolaxy Secures IND Approval for Oral Insulin [0] AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer [0] Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference

... Integrated Global Services, CAMBRIDGE, Mass., Ap...launches under a new name, Abt Bio-Pharma Solution...es Inc. The company will continue to,provide custo...for the,pharmaceutical, biotechnology, medical dev...proach that blends decades of experience with wide...

...08 Cardium Therapeutics,(Amex: CXM ) and its ope...at,InnerCool has entered into a European commercia...Euromed), a leading distributor of cardiology,medi...romed will have,exclusive marketing, sales and dis...nd for InnerCool,s portfolio of temperature modula...

... 1, 2008 Derma Sciences,Inc (OTC Bulletin Board: ...reported that sales for 2007 were $34.1 million, a...ported for 2006. Gross margins held steady at 34,p... in new products for the,pipeline, and expanding t...ny reported a loss of $2.3 million or $0.09 loss p...

Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems Derma Sciences Reports Fourth Quarter Year-End Results for 2007

(Date:11/25/2009)...e course of a lifetime, the heart pumps some 250 m...der to do this, the muscle fibers of the heart hav...ed by Dr. Wolfgang Rottbauer, vice chair of the De...Hospital (Chairman: Prof. Dr. H. A. Katus), has di...bility of the smallest muscular unit, the sarcomer...

(Date:11/24/2009)...us Research Institute (LRI) today named 12 new gra...million, recognize innovative work across a broad ...their creativity, novelty, and potential to drive ... and cure the complex disease of systemic lupus. ,...lupus researchers across the nation and include in...

(Date:11/24/2009)...mic-level action of a remarkable class of ring-sha...rs with the Lawrence Berkeley National Laboratory ...ystallography beamline at the Advanced Light Sourc...n gene expression and replication, and are vital t... infectious agents, such as the human papillomavir...

Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2 Lupus Research Institute announces 2009 novel research grants 2 Lupus Research Institute announces 2009 novel research grants 3 Atomic-level snapshot catches protein motor in action 2 Atomic-level snapshot catches protein motor in action 3 Atomic-level snapshot catches protein motor in action 4 NIMBioS hosts tutorial on optimal control and optimization for biologists 10071 1 New Parkinsons Drug Draws Mixed Reviews 58192 1 New Parkinsons Drug Draws Mixed Reviews 58192 2 New Parkinsons Drug Draws Mixed Reviews 58192 3 Minorities Less Likely to Have Blood Pressure Under Control 58190 1 Minorities Less Likely to Have Blood Pressure Under Control 58190 2 Minorities Less Likely to Have Blood Pressure Under Control 58190 3

[1] New genetic cause of cardiac failure discovered [2] Lupus Research Institute announces 2009 novel research grants [1] Atomic-level snapshot catches protein motor in action

..., , Svilen Bobev, assistant professor of chemistry...ce Foundation,s prestigious Faculty Early Career D...g award, designed to support the integrated resear...their careers, is bestowed on those scientists and...ic leaders of the 21st century. Fewer than 20 perc...

..., Researchers from the University of North Caroli...mechanism that may account for the development of ...e born with in the US every year. The findings, p...oS Computational Biology, add new knowledge to und... also point the way to new corrective treatments. ...

..., NEW YORK (Feb. 28, 2007) -- The general public ...ase (CKD) is a serious and progressive medical con...ed. Understandably so, since in its early stages C...the disease and their health-care providers unawar...r, if CKD is detected and treated early, its wides...

Other Biology News:UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals 2 UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals 3 Computer simulations point to key molecular basis of cystic fibrosis 2 Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines 2 Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines 3 Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines 4

UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals Computer simulations point to key molecular basis of cystic fibrosis Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines

T4 Polynucleotide Kinase Exchange Reaction Buffer from Invitrogen

IMAGEQUANT 400 IQTL from GE Healthcare, formerly Amersham Biosciences

IMAGEQUANT 100 WKSTN from GE Healthcare, formerly Amersham Biosciences

FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems

Biology Products:

T4 Polynucleotide Kinase Exchange Reaction Buffer from Invitrogen IMAGEQUANT 400 IQTL from GE Healthcare, formerly Amersham Biosciences IMAGEQUANT 100 WKSTN from GE Healthcare, formerly Amersham Biosciences FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems

( rsities and top research institutions. ...)The greatest life-science developments of 2004